PO's: N/A Key Research: Leerink upgrades ALNY, UBS upgrades CCE (buy), CLSA upgrades COP, Auriga upgrades SPWRA (buy) Key Research: RBC downgrades FDX & upgrades FITB, Piper upgrades INAP & initiates VIVO (uw), MS initiates GS (ew) Key Research: Chardan upgrades MON (buy), Barclays downgrades HSP &